jesse's journey foundation

The Foundation's Mission Statement In memory of Jessi, we established the Jessi's Journey Foundation. The primary purpose of this foundation is to raise funds to assist families whose child has been diagnosed with brain cancer and to provide an annual scholarship to a student who is majoring in early childhood education at the University of Mount Union.

Bringing hope with a smile

Jesse's Journey (French: le Reve de Jesse) ... This allowed The Foundation for Gene and Cell Therapy to create the Jesse Davidson Endowment - a fund that in 2015 stands at $11M and is a vehicle through which Jesse's Journey can fund research in perpetuity, until a cure is found.

Jessi's Journey Foundation. 376 likes · 2 talking about this. The purpose of this foundation is to raise funds to assist families whose child has brain cancer Jessi's Journey Foundation

John and Jesse Davidson founded Jesse's Journey in 1995 to lead research, advocacy and support in the fight to defeat Duchenne muscular dystrophy. Since then, we've united families, raised awareness and funded $17.73 million in research projects around the world. Their vision remains our foundation: a future without Duchenne.

The story of Jesse's Journey began in 1995, when John Davidson set out to push his 15-year-old son 3,300 kilometres across Ontario in his wheelchair. At the time of Jesse's diagnosis, there ...

In 2022, Jesse's Journey (The Foundation for Gene and Cell Therapy) became Defeat Duchenne Canada (The Jesse Davidson Foundation). We are the country's only national charity dedicated to ending Duchenne and will continue until a cure is found to ensure our boys can live long and active lives.

Published Feb. 17, 2022 9:30 a.m. PST. Share. London-based charity Jesse's Journey has rebranded itself as Defeat Duchenne Canada. Its goal remains the same though, to help raise funds and ...

Officials with Jesse's Journey say the charity has invested more than $14.7 million in research projects around the world since its founding. Duchenne muscular dystrophy impacts approximately ...

Defeat Duchenne Canada relies on the support of individuals and businesses from coast to coast to help make life better for boys and young men living with Duchenne muscular dystrophy, and ultimately, find a cure for this life-limiting disease. Get the latest news on Duchenne research, events, support & education, and ways you can help to defeat ...

A charity based in London, Ont., has undergone a name change, but says its mission remains the same.. Jesse's Journey is now Defeat Duchenne Canada and continues to raise awareness and funds for ...

The award, worth about $1.4 million, is the largest one-year amount awarded in the charity's 26-year history. "Jesse's Journey is a partnership of scientists and families who help fund the research that fundamentally reshapes how boys and men live with Duchenne," Perry Esler, the group's executive director, said in a press release. "This focus and fundraising effort have brought us ...

Duchenne muscular dystrophy is a genetically-based disorder that affects mostly boys and causes a gradual decline in muscle function. It affects approximatel...

MIDDLESEX, ONT. -- London, Ont.-based Jesse's Journey is granting $1.7 million to four research projects on Duchenne muscular dystrophy. It is the largest annual amount in the organization's 26 ...

LONDON, ON, Feb. 17, 2022 /CNW/ - Jesse's Journey, Canada's only national charity dedicated to ending the most common and most fatal form of muscular dystrophy has become Defeat Duchenne Canada.

The Jesse's Journey organization is holding a special fundraising dinner Tuesday to mark the 20th anniversary of Davidson's walk and to screen a new documentary about the cause.

Jesse's Journey is a Canadian charity focused on funding research into Duchenne muscular dystrophy. Founded in 1994 and named for Jesse Davidson, Jesse's Journey is based out of London, Ontario, with a satellite office in Montreal, Quebec. Jesse's Journey is the only Canadian charity that solely exists to fund research into Duchenne.

LONDON, ON, June 10, 2020 /CNW/ - Jesse's Journey, Canada's leader in Duchenne muscular dystrophy funded research, is proud to announce a $1M grant towards a clinical trial evaluating vamorolone in children and adolescents living with Duchenne, the most common fatal genetic disease diagnosed in childhood.. This announcement marks two ground-breaking achievements for the Canadian charity ...

JOHN AND JESSE Davidson from London, Ontario, founded Jesse's Journey in 1995 to provide leadership in research, advocacy and support in the fight to defeat Duchenne muscular dystrophy. They've united families, raised awareness, and become the country's largest funder of Duchenne research ― investing almost $15 million in more than 50 ...

Executives: : Perry Esler - Executive Director [email protected] Rick Moss - National Director, Strategic Partnerships [email protected]